RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $650,474 | +39.5% | 28,374 | +0.3% | 0.00% | – |
| Q2 2023 | $466,271 | -95.2% | 28,276 | -91.5% | 0.00% | -100.0% |
| Q4 2022 | $9,734,030 | +5023.2% | 334,273 | +1925.0% | 0.00% | – |
| Q1 2022 | $190,000 | -21.8% | 16,507 | -31.9% | 0.00% | – |
| Q4 2021 | $243,000 | -31.9% | 24,248 | -11.3% | 0.00% | – |
| Q3 2021 | $357,000 | -27.9% | 27,333 | +8.0% | 0.00% | – |
| Q2 2021 | $495,000 | +35.2% | 25,308 | +47.1% | 0.00% | – |
| Q1 2021 | $366,000 | -15.7% | 17,207 | +17.8% | 0.00% | – |
| Q4 2020 | $434,000 | +100.9% | 14,612 | +46.6% | 0.00% | – |
| Q3 2020 | $216,000 | -4.4% | 9,964 | -1.7% | 0.00% | – |
| Q2 2020 | $226,000 | +33.7% | 10,134 | -8.9% | 0.00% | – |
| Q1 2020 | $169,000 | – | 11,127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |